| Study Period | 2021 - 2030 |
| Base Year For Estimation | 2024 |
| Market Size (2025) | USD 13.13 Billion |
| Market Size (2030) | USD 24.07 Billion |
| CAGR (2025 - 2030) | 12.89% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Continuous Glucose Monitoring (CGM) Market Analysis
The Continuous Glucose Monitoring Market size is estimated at USD 13.13 billion in 2025, and is expected to reach USD 24.07 billion by 2030, at a CAGR of 12.89% during the forecast period (2025-2030).
Diabetes accounts for a significant portion of healthcare spending. Thus, it requires increased epidemiological surveillance, treatment, and preventive measures. Various companies help reduce these costs and improve the health and well-being of people through programs that target disease prevention and management. Hence, these factors are expected to fuel the growth of the Continuous Glucose Monitoring devices market.
Diabetes is anticipated to persist as a significant concern in the coming years, mainly attributed to lifestyle changes. Type 1 diabetes is strongly linked to a family history of the condition in a few countries like the United States and India, but the exact cause is unknown. Nonmodifiable factors increase the risk for Type 1 diabetes, though maintaining a healthy lifestyle is important for managing the symptoms and long-term complications associated with the condition. Thus, the prevalence of diabetes globally is projected to experience significant growth during the forecast period, thereby boosting the CGM market for effective disease control and management through devices such as Continuous Glucose Monitors (CGMs).
As per the International Diabetes Federation (IDF), Africa is projected to witness a 134% surge in the diabetic population from 2021 to 2045, whereas North America and the Caribbean are expected to experience a 24% increase in the disease population. By 2045, China is likely to have the highest number of individuals affected by diabetes globally. According to the International Diabetes Federation 2022 reports, the prevalence of diabetes in adults in the United States was about 11.8% in 2022. Thus, such a high prevalence is expected to drive the demand for Continuous Glucose Monitoring (CGM) devices for effective disease control, thereby augmenting the CGM market growth over the forecast period.
Continuous Glucose Monitoring devices help Type 1 and Type 2 diabetes patients manage their diabetes with fewer fingerstick tests. These devices are part of the Wearable Glucose Monitoring technology to track glucose levels through apps. Most CGM devices, key products in the CGM industry, take readings every five to ten minutes all day long. CGM devices have a wireless transmitter to transfer the CGM data from the sensor to the receiver.
Therefore, the rising prevalence of diabetes and the increasing demand for Continuous Glucose Monitoring devices are anticipated to bolster the CGM market growth over the forecast period.
Continuous Glucose Monitoring (CGM) Market Trends
The Sensors Segment is Expected to Hold a Major Market Share Over the Forecast Period
The CGM sensor, a key component in the Glucose Sensor market, is a device that can be implanted beneath the patient's skin, typically on the belly or arm, using an adhesive patch to secure it in place. These sensors are designed for single-use and are referred to as disposable sensors.
Alternatively, there is another type of CGM sensor known as an implantable sensor, which can be inserted inside the patient's body. These sensors measure the glucose level in the fluid surrounding the cells, which closely corresponds to the glucose level in the patient's blood. These implantable devices represent a significant segment of the Implantable Continuous Glucose Monitoring System market. Depending on the specific sensor type, they need to be replaced at regular intervals, such as every few weeks.
New innovations in the Continuous Glucose Monitoring devices market are further driving the market growth. For instance, in March 2024, the Food and Drug Administration (FDA) granted clearance for Dexcom's latest over-the-counter Continuous Glucose Monitor, known as Stelo. This innovative CGM is specifically tailored for individuals with Type 2 diabetes who do not rely on insulin, making it a groundbreaking development in the field. Stelo is the first Glucose Biosensor that can be obtained without a prescription, providing greater accessibility for patients. With the Glucose Biosensor anticipated to hit the market by end of 2024, individuals will have the opportunity to purchase Stelo and benefit from its advanced features, potentially impacting Dexcom market share in the industry.
In February 2024, Dexcom ONE+ system was accessible in Spain, Belgium, and Poland, with plans for a future launch in the Netherlands and other European countries. In certain regions, Dexcom ONE+ will be taking the place of the earlier Dexcom ONE sensor. Dexcom ONE+ utilizes the most precise sensor technology; the company considered input from both users and medical experts during the development of Dexcom ONE+, ensuring a user-friendly and highly efficient CGM solution for individuals managing Type 1 or Type 2 diabetes with insulin. These advancements may enhance Dexcom's CGM market share in the competitive landscape.
Therefore, the launch of such devices using advanced technologies may propel the CGM market growth during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the CGM Device Market
North America possesses a highly sophisticated healthcare infrastructure with an extensive network of advanced hospitals and diabetes care facilities well-equipped with cutting-edge technology, facilitating the widespread adoption of Continuous Glucose Monitoring products.
The region is expected to experience significant CGM market growth over the forecast period, mainly attributed to the rising prevalence of chronic diseases like diabetes. The increase in technological advancements is expected to boost market growth over the forecast period. Market growth is also fueled by the increasing geriatric population and rising focus on non-invasive monitoring. The prevalence of diabetes has increased in the United States dramatically in recent years. For instance, as per the National Center for Health Statistics in November 2024, between August 2021 and August 2023, diabetes prevalence increased with weight. It was 6.8% in underweight or normal-weight adults, 12.3% in overweight individuals, and 24.2% in obese adults. Diagnosed diabetes followed a similar pattern, rising from 5.2% in underweight or normal-weight adults to 9.5% in overweight individuals and 16.3% in obese adults. Undiagnosed diabetes also increased from 1.6% in underweight or normal-weight adults to 2.8% in overweight individuals and 7.9% in obese adults.
According to a report published by Diabetes Canada in July 2023, more than 11.9 million people in Canada are living with diabetes or prediabetes. This rising prevalence of diabetes in the country is creating demand for Continuous Glucose Monitoring, thereby propelling the growth of the Continuous Glucose Monitoring market.
Several key players in the Continuous Glucose Monitoring market, such as Dexcom Inc., Abbott, Signos Inc., and Senseonics Holdings Inc., are present in the country. These Continuous Glucose Monitoring companies are constantly working on innovating novel technologies to capture a higher market share. This is expected to increase the demand for Continuous Glucose Monitoring devices, thereby propelling the market growth. For instance, in March 2024, the FDA greenlit marketing for the Dexcom Stelo Glucose Biosensor System, contributing to the growth of the Glucose Biosensor market. This device is one of the first over-the-counter (OTC) CGMs available for purchase, potentially expanding Dexcom's CGM market share. The device will be available in summer 2024.
The increasing prevalence of diabetes in North America is driving significant CGM market growth, fueled by technological advancements, with key Continuous Glucose Monitoring market players continually innovating new technologies.
Get Analysis on Important Geographic Markets
Download PDF
Continuous Glucose Monitoring (CGM) Industry Overview
The Continuous Glucose Monitoring market is consolidated and consists of a few major players. Some CGM companies currently dominating the market are Dexcom, Abbott, and Medtronic. A major share of the market is held by CGM manufacturers that are concurrent with strategy-based M&A operations. They are constantly entering new markets to generate new revenue streams and boost existing ones. These measures taken by the Continuous Glucose Monitoring market players will ensure a competitive marketplace, forcing the companies to experiment with newer technologies to ensure uniqueness in their products. One of the implications of the competition in the market is that it will ensure a constant decrease in the average selling price of the CGM units produced. Companies are collaborating to increase their technological know-how and to fasten the product development cycle.
Continuous Glucose Monitoring (CGM) Market Leaders
-
Medtronic Plc
-
Dexcom, Inc.
-
Abbott Laboratories
-
Senseonics Holdings, Inc.
-
F. Hoffmann-La Roche AG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Continuous Glucose Monitoring (CGM) Market News
- March 2024: The Dexcom Stelo Glucose Biosensor System, an integrated CGM (iCGM), was granted marketing clearance by the US Food and Drug Administration. The device is designed for individuals aged 18 and above who do not require insulin, including those with diabetes managing their condition through oral medications and those without diabetes who wish to gain insights into the effects of diet and exercise on their blood sugar levels.
- May 2023: Dexcom showcased G6 CGM at the 66th Annual Meeting of the Japan Diabetes Society. This system offers real-time glucose data to diabetes patients without the need to prick the finger.
Continuous Glucose Monitoring (CGM) Industry Segmentation
As per the scope of the report, patients can manage type 1 or type 2 diabetes with the use of continuous glucose monitoring (CGM) devices by performing fewer fingerstick tests. Blood sugar levels are continuously monitored by a sensor located just under the skin. Results are sent via a transmitter to a cell phone or wearable technology. The continuous glucose monitoring market is segmented by component, end user, and geography. By component, the market is segmented into sensors and durables. The end user segment is further divided into hospitals/clinics and home/personal. The report also covers the market sizes and forecasts for major countries across different regions. The market size is provided for each segment in terms of value (USD).
| By Component | Sensors | ||
| Durables(Receivers and Transmitters) | |||
| By End User | Hospital/Clinics | ||
| Home/Personal | |||
| Geography | North America | United States | |
| Canada | |||
| Rest of North America | |||
| Europe | France | ||
| Germany | |||
| Italy | |||
| Spain | |||
| United Kingdom | |||
| Russia | |||
| Rest of Europe | |||
| Latin America | Mexico | ||
| Brazil | |||
| Rest of Latin America | |||
| Asia-Pacific | Japan | ||
| South Korea | |||
| China | |||
| India | |||
| Australia | |||
| Vietnam | |||
| Malaysia | |||
| Indonesia | |||
| Philippines | |||
| Thailand | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | Saudi Arabia | ||
| Iran | |||
| Egypt | |||
| Oman | |||
| South Africa | |||
| Rest of Middle East and Africa | |||
By Component
| Sensors |
| Durables(Receivers and Transmitters) |
By End User
| Hospital/Clinics |
| Home/Personal |
Geography
| North America | United States |
| Canada | |
| Rest of North America | |
| Europe | France |
| Germany | |
| Italy | |
| Spain | |
| United Kingdom | |
| Russia | |
| Rest of Europe | |
| Latin America | Mexico |
| Brazil | |
| Rest of Latin America | |
| Asia-Pacific | Japan |
| South Korea | |
| China | |
| India | |
| Australia | |
| Vietnam | |
| Malaysia | |
| Indonesia | |
| Philippines | |
| Thailand | |
| Rest of Asia-Pacific | |
| Middle East and Africa | Saudi Arabia |
| Iran | |
| Egypt | |
| Oman | |
| South Africa | |
| Rest of Middle East and Africa |
Need A Different Region or Segment?
Customize Now
Continuous Glucose Monitoring (CGM) Market Research Faqs
How big is the Continuous Glucose Monitoring Market?
The Continuous Glucose Monitoring Market size is expected to reach USD 13.13 billion in 2025 and grow at a CAGR of 12.89% to reach USD 24.07 billion by 2030.
What is the current Continuous Glucose Monitoring Market size?
In 2025, the Continuous Glucose Monitoring Market size is expected to reach USD 13.13 billion.
Who are the key players in Continuous Glucose Monitoring Market?
Medtronic Plc, Dexcom, Inc., Abbott Laboratories, Senseonics Holdings, Inc. and F. Hoffmann-La Roche AG are the major companies operating in the Continuous Glucose Monitoring Market.
Which is the fastest growing region in Continuous Glucose Monitoring Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Continuous Glucose Monitoring Market?
In 2025, the North America accounts for the largest market share in Continuous Glucose Monitoring Market.
What years does this Continuous Glucose Monitoring Market cover, and what was the market size in 2024?
In 2024, the Continuous Glucose Monitoring Market size was estimated at USD 11.44 billion. The report covers the Continuous Glucose Monitoring Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Continuous Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Continuous Glucose Monitoring (CGM) Industry Report
The global continuous glucose monitoring (CGM) market is experiencing significant growth, driven by the increasing prevalence of diabetes worldwide. The market size is expanding rapidly, particularly in regions with aging populations and rising obesity rates. Technological advancements in CGM devices, such as sensors and transmitters, are enhancing their accuracy and user-friendliness, contributing to market growth.
In terms of market segmentation, the CGM market is divided into components like sensors and durables, which include receivers and transmitters. The market value of these segments is increasing due to the growing demand for continuous and non-invasive glucose monitoring solutions. Homecare settings are a major end-use segment, where CGM devices improve comfort and health management for users. Hospitals are also adopting these devices for efficient diabetes management.
North America currently dominates the CGM market, thanks to its well-established healthcare infrastructure and high prevalence of diabetes. However, the Asia-Pacific region is expected to show the highest growth rate, driven by increasing diabetes awareness, rising healthcare expenditure, and the availability of advanced medical technologies.
Industry reports indicate that CGM companies are continuously innovating and expanding their market presence globally. This industry outlook suggests a positive market forecast, with significant market predictions for future growth. Market leaders in the CGM industry are focusing on market data and market review to stay ahead of trends and maintain their competitive edge.
For those interested in detailed industry information, industry analysis, and industry statistics, a comprehensive market report is available. This report provides valuable insights into market trends, market overview, and market segmentation. It also includes a report pdf for easy reference and a report example for better understanding.
Research companies are actively involved in market research to provide accurate market analysis and market overview. The industry research highlights the importance of market growth and market outlook in shaping the future of the CGM market. Industry sales and industry size are also critical factors that contribute to the overall market dynamics.
In conclusion, the CGM market is poised for substantial growth, supported by technological advancements and increasing demand for efficient diabetes management solutions. The market forecast remains positive, with significant opportunities for market leaders and new entrants alike. For a detailed analysis and comprehensive insights, refer to the industry reports available from Mordor Intelligence™.
